Yarrow Bioscience (YARW) Assets (2016 - 2026)

Yarrow Bioscience (YARW) has reported Assets for 11 consecutive years, with $23.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets fell 47.22% year-over-year to $23.6 million; the trailing twelve-month figure through Jun 2026 stood at $23.6 million (down 47.22% YoY), and the FY2025 full-year result was $30.2 million, down 54.92% from the prior year.
• Assets declined to $23.6 million in Q2 2026 per YARW's latest filing, from $25.9 million in the prior quarter.
• Across five years, Assets topped out at $97.7 million in Q4 2023 and bottomed at $19.3 million in Q3 2023.
• Historically, Assets has averaged $52.2 million across 5 years, with a median of $46.9 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Assets slumped 58.93% in 2023, then soared 295.48% in 2024.
• Over 5 years, Assets stood at $40.8 million in 2022, then jumped by 139.67% to $97.7 million in 2023, then tumbled by 31.51% to $66.9 million in 2024, then plunged by 54.92% to $30.2 million in 2025, then dropped by 21.74% to $23.6 million in 2026.
• According to Business Quant data, Assets over the past three periods registered $23.6 million, $25.9 million, and $30.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.